⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Official Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Patients With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Study ID: NCT04540211

Study Description

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of atezolizumab plus tiragolumab in combination with paclitaxel and cisplatin (PC) compared with atezolizumab matching placebo plus tiragolumab matching placebo plus PC as first-line treatment in participants with unresectable locally advanced, unresectable recurrent, or metastatic esophageal carcinoma (EC). Participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during induction phase: Arm A: Atezolizumab plus Tiragolumab and PC Arm B: Atezolizumab placebo plus Tiragolumab placebo and PC Following the induction phase, participants will continue maintenance therapy with either atezolizumab plus tiragolumab (Arm A) or atezolizumab matching placebo plus tiragolumab matching placebo (Arm B).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Anyang Tumor Hosptial, Anyang City, , China

Beijing Luhe Hospital Capital Medical University, Beijing City, , China

Beijing Cancer Hospital, Beijing, , China

the First Hospital of Jilin University, Changchun, , China

Jilin Cancer Hospital, Changchun, , China

Hunan Cancer Hospital, Changsha CITY, , China

Affiliated Hospital of Chengde Medical University, Chengde City, , China

Sichuan Provincial Cancer Hospital, Chengdu, , China

West China Hospital, Sichuan University, Chengdu, , China

Chongqing Sanxia Central Hospital, Chongqing City, , China

The First People's Hospital of Foshan; Local Ethic Committee, Foshan, , China

Fujian Provincial Hospital, Fuzhou City, , China

Fujian Cancer Hospital, Fuzhou, , China

Southern Medical University Nanfang Hospital, Guangdong Province Guangzhou City, , China

Harbin Medical University Cancer Hospital, Harbin, , China

Anhui Province Cancer Hospital, Hefei City, , China

Anhui Provincial Hospital, Hefei, , China

The Second Affiliated Hospital of Anhui Medical University, Hefei, , China

Huai'an First People's Hospital, Huai'an City, , China

The Second People's Hospital of Huai'an, Huai'an City, , China

Affiliated Hopsital of Jining Medical University, Jining, , China

Gansu Province People Hospital, Lanzhou, , China

The First People's Hospital of Lian Yun Gang, Lianyungang, , China

Linyishi Cancer Hospital, Linyi City, , China

The First Affiliated Hospital to Henan University of Science and Technology, Luoyang City, , China

Jiangsu Province Hospital of Chinese Medicine, Nanjing City, , China

Jiangsu Cancer Hospital, Nanjing City, , China

Nan Tong Tumor Hospital, Nantong City, , China

Fudan University Shanghai Cancer Center, Shanghai City, , China

Shanghai Chest Hospital, Shanghai, , China

Zhongshan Hospital Fudan University, Shanghai, , China

Cancer Hospital of Shantou University Medical College, Shantou, , China

Liaoning Provincial Cancer Hospital, Shengyang, , China

The University of Hong Kong-Shenzhen Hospital; Local Ethic Committee, Shenzhen City, , China

Suining Central Hospital, Suining, , China

Tianjin Cancer Hospital, Tianjin, , China

Weifang People's Hospital, Weifang City, , China

Wuhan Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, , China

Hubei Cancer Hospital, Wuhan, , China

Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ), Wuxi City, , China

The Second Affiliated Hospital of The Fourth Military Medical University (Tangdu Hospital), Xi'an, , China

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, , China

The First Affiliated Hospital of Xiamen University, Xiamen, , China

Zhongshan Hospital Xiamen University, Xiamen, , China

Xiangyang Central Hospital, Xiangyang, , China

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang City, , China

Xuzhou Central Hospital, Xuzhou, , China

Northern Jangsu People's Hospital, Yangzhou City, , China

Zhejiang Cancer Hospital, Zhejiang, , China

Henan Cancer Hospital, Zhengzhou, , China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, , China

Queen Mary Hospital; Dept. of Clinical Oncology, Hong Kong, , Hong Kong

Prince of Wales Hosp; Dept. Of Clinical Onc, Shatin, , Hong Kong

Kyungpook National University Chilgok Hospital, Daegu, , Korea, Republic of

National Cancer Center, Goyang-si, , Korea, Republic of

Seoul National University Bundang Hospital, Seongnam-si, , Korea, Republic of

Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of

Asan Medical Center, Seoul, , Korea, Republic of

Samsung Medical Center, Seoul, , Korea, Republic of

Korea University Guro Hospital, Seoul, , Korea, Republic of

Chang Gung Medical Foundation - Kaohsiung; Oncology, Kaohisung, , Taiwan

National Cheng Kung University Hospital; Oncology, Tainan, , Taiwan

Taipei Veterans General Hospital; Department of Oncology, Taipei City, , Taiwan

National Taiwan University Hospital; Oncology, Zhongzheng Dist., , Taiwan

Chulalongkorn Hospital; Medical Oncology, Bangkok, , Thailand

Rajavithi Hospital; Division of Medical Oncology, Bangkok, , Thailand

Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc, Bangkok, , Thailand

Siriraj Hospital; Medical Oncology Unit, Bangkok, , Thailand

Songklanagarind Hospital; Department of Oncology, Songkhla, , Thailand

Contact Details

Name: Clinical Trials

Affiliation: Hoffmann-La Roche

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: